Discover why Incyte's strong growth trajectory and upcoming product launches make it an attractive investment with a ...

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

A blockbuster drug is a therapy that generates at least $1 billion in sales. Clarivate’s Drugs to Watch 2025 report includes ...

GLP-1 drugs mimic a hormone in the intestinal tract to balance the body’s blood sugar levels. And while GLP-1 drugs such as ...

With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.

A WOMAN has discovered a super cheap Superdrug find that works just like Botox – and the results have completely blown her ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Corvus Pharmaceuticals (CRVS) stock was granted a new buy recommendation by H.C. Wainwright based on its lead asset, despite its recent selloff. Read more here.

MY-004 is under clinical development by Createrna Science and Technology and currently in Phase II for Atopic Dermatitis (Atopic Eczema).

Innovative Drug Delivery Technologies: The market is characterized by the adoption of innovative drug delivery technologies, including topical creams, gels, foams, and transdermal patches. These ...

INR:6060. today match score live world cup First ICV injection for enzyme replacement therapy for Hunter syndrome approved in ...

RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for 12 of 15 patients within four weeks. The condition primarily affects ...